Afuco™ Anti-ERBB3 ADCC Therapeutic Antibody (Seribantumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human ERBB3. Seribantumab is used to treat cancer.
Supplier Creative Biolabs
Product # AFC-TAB-892
Pricing Inquiry
Host Human
Target ERBB3
Species Reactivity Human
Type ADCC enhanced antibody
Applications IF, IP, Neut, FuncS, ELISA, FC
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback